शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEMAKERS LABORATORIES LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 7 Aug, 2026 · 12:02 IST

Q1 FY27 results and CEO transition at Makers Labs

Pat Growth 25pctPat NegativeResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.6%Reaction day
₹165.90
prior close
₹172.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-3.6% vs market
Pharmaceuticals peers, median of 168sector+0.3%-3.8% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 3.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-3.5
15m
-7.0
30m
-7.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.6+0.0-3.6+0.3-3.8
Next day
-7.0-0.0-7.0+0.7-7.7
2d
-2.0-0.2-1.9+0.6-2.6
3d
-4.9+0.2-5.1+0.4-5.3
4d
-7.8+0.3-8.1+1.2-9.0
5d
-6.0+0.4-6.4+0.2-6.2
1w
—+0.9—+0.2—
15d
—+1.6—+1.1—
1m
—+2.0—+2.4—
2m
—+0.6—+1.6—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Makers Laboratories Q1 FY27 results (quarter ended June 30, 2026): Consolidated revenue rose 19.6% YoY to Rs 42.77 crores, PAT after non-controlling interest up 150% at Rs 1.09 crores (EPS Rs 1.85). Standalone in loss at Rs 1.07 crores (EPS minus Rs 1.82), wider than Rs 0.96 crores loss in Q1 FY26. CEO Saahil Parikh ends Whole-time Director term on August 10, 2026, continues as Non-Executive Director. Auditor issued unmodified review report.

Likely market impact

Consolidated profitability improved sharply but standalone business still loss-making. CEO transition to non-executive role is a notable leadership change.